Examining self-efficacy and medication adherence in coronary artery disease patients
Investigation of the Relationship Between Self-Efficacy and Adherence to Medication in Individuals With Coronary Artery Disease: A Descriptive and Correlational Study
This study is trying to see how believing in themselves helps people with coronary artery disease stick to their medication plans.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 135 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Hasan Kalyoncu University Academic / other |
| Locations | 1 site (Adıyaman) |
| Trial ID | NCT06943157 on ClinicalTrials.gov |
What this trial studies
This descriptive study investigates the relationship between self-efficacy and medication adherence in individuals diagnosed with coronary artery disease (CAD). Conducted at Adıyaman University Training and Research Hospital, the study will enroll 135 participants and utilize validated scales to assess self-efficacy and medication adherence. Data collection will occur between March and October 2025, focusing on patients who have had CAD for at least one year. The findings aim to enhance understanding of how self-efficacy influences treatment adherence in CAD patients.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older who have been diagnosed with coronary artery disease for at least one year.
Not a fit: Patients with primary diagnoses other than coronary artery disease or those unable to complete the questionnaires due to mental health issues may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved medication adherence and health outcomes for patients with coronary artery disease.
How similar studies have performed: Previous studies have shown a positive correlation between self-efficacy and medication adherence in chronic disease management, suggesting this approach is supported by existing literature.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Being 18 years of age or older Having been diagnosed with Coronary Artery Disease (angina pectoris, unstable angina, myocardial infarction) at least 1 year ago Being followed Being able to communicate in Turkish Voluntarily agreeing to participate in the study Having no diagnosed mental disorder Exclusion Criteria: * Having a primary diagnosis other than Coronary Artery Disease Being unable to complete the questionnaires due to mental health problems Providing incomplete data or withdrawing from the study
Where this trial is running
Adıyaman
- Adiyaman University Training and Research Hospital — Adıyaman, Turkey (Türkiye) (Recruiting)
Study contacts
- Study coordinator: ZEYNAL KİZİR, PhD Student
- Email: zkizir0234@gmail.com
- Phone: +9005446445202
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.